Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆
Top Cited Papers
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Neurobiology of Aging
- Vol. 21 (1) , 27-30
- https://doi.org/10.1016/s0197-4580(99)00103-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesisPublished by Elsevier ,2002
- Brain Expression of Apolipoproteins E, J, and A‐I in Alzheimer's DiseaseJournal of Neurochemistry, 1996
- Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Amyloid β binding proteins in vitro and in normal human cerebrospinal fluidNeuroscience Letters, 1995
- Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- The Soluble Form of Alzheimer′s Amyloid β Protein Is Complexed to High Density Lipoprotein 3 and Very High Density Lipoprotein in Normal Human PlasmaBiochemical and Biophysical Research Communications, 1994
- Brain Uptake of Circulating Apolipoproteins J and E Complexed to Alzheimer′s Amyloid βBiochemical and Biophysical Research Communications, 1994
- Structure and stability of apolipoprotein J-containing high-density lipoproteinsBiochemistry, 1992
- A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.Journal of Clinical Investigation, 1989
- “Mini-mental state”Journal of Psychiatric Research, 1975